American financier, author, and founder of one of the biggest investment management companies, Kenneth Lawrence Fisher. Ken Fisher, born in 1950, gained his knowledge and aptitude for the stock market from his famed stock investor father. The three pillars of Ken Fisher’s investment approach are taking risks, diversification, and taking advantage of opportunities. The company’s managed 13F securities totaled more than $169 billion as of the first quarter of 2022. The defensive equities in Kenneth Fisher’s Fisher Asset Management portfolio will be covered in this article. It seems like a good moment to think about investing in some defensive equities given that inflation is at a four-decade high. The least volatile stocks are those that supply essential services like healthcare, consumer staples, industrial equipment, and utilities. Defensive stocks have a low-risk profile, but they won’t benefit much during bull markets as a result.
Insider Monkey shares the 10 defensive stocks that Ken Fisher loves. One of Ken Fisher’s top ten defensive options is the pharmaceutical behemoth Johnson & Johnson, which largely avoids being impacted by macroeconomic headwinds. The company’s dividend yield is 2.57 percent, and over the last 12 months, it has given investors a return of 11.57 percent. In its third-quarter 2022 results, The Proctor & Gamble Company claimed organic growth of 10% and a 3% increase in sales volume. In the first quarter of 2022, GQG Partners held the largest interest in the business, valued at $1.515 billion. The British corporation Unilever PLC manufactures consumer goods. On June 16, the company teamed up with Genomatica to market substitutes for cleaning products generated from palm oil and fossil fuels. The company’s financials have not suffered because of the weak economy. The multi-industry Caterpillar Inc. produces and markets heavy equipment, engines, and financial services. Compared to the industry average of 1.26 percent, the company’s dividend yield is 2.16 percent. Novo Nordisk A/S, is one of the least volatile firms in Fisher Asset Management’s portfolio, with a five-year monthly beta of 0.24. The business outperformed the Large Cap Pharmaceuticals industry average, which was +19.3 percent, with a performance of +36.9 percent. For more details, click Ken Fisher Loves These 10 Defensive Stocks.
